Search | Page 10 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

    ... must have one of the following disease types: Acute myeloid leukemia (AML) with disease features as described in the ... disease features as described in the protocol. Chronic myelogenous leukemia (CML) with disease features as described in the protocol. ...

    Clinical Trial last updated 06/06/2016 - 3:37pm.

  2. Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

    ... must have one of the following disease types: Acute myeloid leukemia (AML) with disease features as described in the ... disease features as described in the protocol. Chronic myelogenous leukemia (CML) with disease features as described in the protocol. ...

    Clinical Trial last updated 06/03/2016 - 2:54pm.

  3. Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease

    ... is expected. This includes, but is not limited to: Acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) in first complete remission Chronic myelogenous leukemia (CML) in chronic phase with tyrosine kinase inhibitor ...

    Clinical Trial last updated 06/06/2016 - 3:04pm.

  4. Phase I/II MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell

    ... in pre-defined doses and ratios will reduce the incidence of acute graft vs host disease while augmenting the graft vs leukemia effect and ... karyotype with FLT3-ITD mutation Chronic myelogenous leukemia (accelerated, blast or second chronic phase) ...

    Clinical Trial last updated 05/09/2016 - 3:58pm.

  5. UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep

    ... from zero to 30% but are typically short lived. Acute Leukemias: Must be in remission by morphology (<5% blasts ... CR Natural killer cell malignancies Chronic myelogenous leukemia (CML): all types except refractory blast crisis. ...

    Clinical Trial last updated 04/29/2016 - 10:06am.

  6. Allo HSCT Using RIC for Hematological Diseases

    ... cell infusion. The primary objective is to evaluate rates of acute graft-versus-host disease (GVHD) grades II-IV and chronic GVHD ... once they achieved a complete remission. Chronic Myelogenous Leukemia excluding refractory blast crisis: To be eligible ...

    Clinical Trial last updated 05/02/2016 - 9:29am.

  7. Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)

    ... transplantation. This includes, but is not limited to: acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myelogenous leukemia (CML), chronic lymphocytic leukemia (CLL), non-Hodgkin ...

    Clinical Trial last updated 05/09/2016 - 3:36pm.

  8. Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT01995578 ...

    Clinical Trial last updated 04/27/2016 - 1:19pm.

  9. Ilene Galinsky BSN,MSN,ANP-C

    ... in the diagnosis, treatment, and management of patients with acute and chronic myelogenous leukemia (CML), myelodysplastic syndrome (MDS), myelofibrosis, and ...

    Bio last updated 03/11/2016 - 1:41pm.

  10. CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma

    ... the CD8+ memory T-cell infusion; patients with a history of acute GVHD overall grade II based on skin only involvement or upper ... therapy Acute leukemia not in remission Chronic myelogenous leukemia (CML) Active central nervous system (CNS) involvement ...

    Clinical Trial last updated 04/29/2016 - 12:36pm.